Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 30, 2024

BUY
$191.17 - $325.63 $1,338 - $2,279
7 Added 0.79%
898 $292,000
Q4 2023

Feb 07, 2024

BUY
$160.99 - $215.69 $21,572 - $28,902
134 Added 17.7%
891 $169,000
Q3 2023

Oct 25, 2023

BUY
$194.33 - $283.97 $28,566 - $41,743
147 Added 24.1%
757 $150,000
Q2 2023

Aug 10, 2023

SELL
$223.05 - $302.68 $79,405 - $107,754
-356 Reduced 36.85%
610 $174,000
Q1 2023

May 15, 2023

BUY
$175.41 - $217.92 $47,185 - $58,620
269 Added 38.59%
966 $209,000
Q4 2022

Jan 30, 2023

BUY
$204.38 - $296.82 $114,044 - $165,625
558 Added 401.44%
697 $0
Q3 2022

Nov 15, 2022

BUY
$195.21 - $310.53 $1,561 - $2,484
8 Added 6.11%
139 $39,000
Q2 2022

Aug 09, 2022

BUY
$115.91 - $214.48 $15,184 - $28,096
131 New
131 $25,000
Q1 2022

May 09, 2022

SELL
$127.96 - $207.36 $11,516 - $18,662
-90 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$29.4 - $44.98 $2,646 - $4,048
90 New
90 $4,000
Q3 2019

Nov 13, 2019

SELL
$29.71 - $55.23 $2,673 - $4,970
-90 Closed
0 $0
Q2 2019

Aug 13, 2019

BUY
$29.73 - $66.02 $2,675 - $5,941
90 New
90 $5,000
Q1 2019

May 15, 2019

BUY
$29.41 - $38.1 $0 - $0
0 New
0 $0

Others Institutions Holding SWAV

About Shockwave Medical, Inc.


  • Ticker SWAV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,927,100
  • Description
  • ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...
More about SWAV
Track This Portfolio

Track Concourse Financial Group Securities, Inc. Portfolio

Follow Concourse Financial Group Securities, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.